Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
2 CALLS ON FILE
PCVX
— Vaxcyte, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
FEB 24, 2026
REVENUE
$0
EPS
-$1.81
-16.0%
FREE CASH FLOW
-$219.3M
-41.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 2
OLDER CALL →